Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors (AflacST1502)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02574728
Recruitment Status : Recruiting
First Posted : October 14, 2015
Last Update Posted : August 19, 2019
Cannonball Kids' Cancer Foundation
Hyundai Hope On Wheels
Information provided by (Responsible Party):
Thomas Cash, MD, Emory University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : June 2020